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BI-RADS4 breast lesionsa b s t r a c t
Purpose: The purpose of this study was to evaluate the usefulness of shear wave elastog-
raphy (SWE) versus MRI dynamic curve in discriminating BI-RADS 4 breast masses to
detect which modality is more sensitive and specific.
Patients and methods: Sixty-three patients presented by breast masses and categorized as
BI-RADS 4 by mammography and ultrasound over the study period for 1 year were
included. We analyzed and compared the quantitative dynamic MRI curve types with
E-maximum (E-Max) shear wave (SW) velocity values.
Results: Histopathological evaluation revealed 41.3% of the cases had benign lesions and
58.7% had a malignant lesion. The mean E-max SW value of each pathology and its corre-
sponding dynamic MRI curve were analyzed.
At a cutoff value 45.3 kPa ± 41.1 for benign lesions and 146.6 kPa ± 40.05 for malignant
lesions, the recorded sensitivity, specificity and accuracy of quantitative SWE in differenti-
ating between the benign and malignant BI-RADS 4 breast lesions were 89.5%, 88%, and
88.9%, respectively and those for DC-MRI curve were 100%, 92.3%, and 96.8%, respectively.
Conclusion: Quantitative measurements are more vulnerable in detecting and differentiat-
ing BI-RADS 4 lesions. Type of the dynamic MRI curve is more sensitive, specific and accu-
rate than SWE.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction and good prognosis. A less invasive test is needed to reduceThe high incidence of breast cancer and its slow evolu-
tion before diagnosis have led to research on new diagnos-
tic techniques [1–3]. Early detection of breast cancer with
appropriate staging is very essential for specific treatmentpatient’s anxiety and suffering.
In order to obtain acceptable specificity, various charac-
teristics of the lesions must be evaluated according to the
BI-RADS criteria defined by the American College of Radiol-
ogy (ACR) [2]. However, the overlap in those criteria often
generates a considerable number of false-positive results
[4]. This limitation leads to an increase in biopsies with
cancer ‘‘detection rate” of only 10–30% [5].
The sensitivity of MR imaging for detection of breast
cancer is very high and approaches 100% for invasive carci-
noma. However, the specificity is low and varies between
37 and 70% [6,7]. The factors associated with this wide
1774 G. A. Elmoneam et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1773–1782range of specificity are differences in the study population,
the strength of the magnet, imaging protocols, and inter-
pretation criteria [8].
Dynamic contrast-enhanced breast MRI (DCE-MRI) is
clinically used to provide volumetric three-dimensional
anatomical information and physiologic information that
are indicative of increased vascular density and vascular
permeability changes associated with angiogenesis [9].
DCE-MRI is routinely used to evaluate focal breast
lesions. Adding information derived from kinetic curve
type to architectural features of a lesion improves the
specificity of breast MRI [10,11].
Sono-elastography (SE) differentiates between benign
and malignant lesions on the basis of their elasticity:
benign lesions have an elasticity similar to the surrounding
tissue while malignant lesions are harder than adjacent
tissue [12].
Several clinical studies showed that SE was useful for
differentiating benign and malignant breast lesions, with
a sensitivity of 78.0–100% and specificity of 91.0–98.5%
[13,14]. Real-time tissue elastography may provide
additional characterization of breast lesions, improving
specificity, particularly for low-suspicion lesions [15].2. Patients and methods
2.1. Patients
It is a prospective study carried out in the Radiology
Department, Zagazig University, in the period from
September 2014 to September 2015. A total of 63 patients
with suspicious breast masses (42 palpable and 21 non-
palpable) were included and categorized as BI-RAD 4 using
mammography and ultrasound (US). All patients were sub-
jected to mammography and US evaluation. Approval for
the study from committee board of our institute was taken,
as well as, a written consent from all participants after
explanation of the procedure (imaging research and surgi-
cal approach).
Inclusion criteria:
 BI-RAD 4 lesions, according to the Breast Imaging
Recording and Data System (BI-RADS) criteria for X-




 Previous breast operation.
 Patient with recent breast trauma in the same diseased
breast within the last 6 months.
 Contraindication to perform MRI (as those with Cardiac
pacemaker or Metallic aneurysm clips).
2.2. Imaging methods
2.2.1. Sono-elastography
Both breasts were examined in all patients by conven-
tional B-mode US and images of the target lesions were
primarily obtained. After activating the sono-elastographic function, images were obtained by applying
repeated compression and decompression in a sustained
frequency. The vibration force was created by focusing
ultrasound beams at six different depths; successive focus-
ing depths were separated by 5 mm, for 3 cm depth. This
supersonic energy made plane shear waves that spread
transversally through the tissue in a few tens of millisec-
onds. The resulting images of the shear wave’s velocity
were displayed as a real-time overlay on the simultane-
ously acquired B-mode. The color scale was calibrated in
kilopascals (kPa) ranging from 0 to 240 kPa. Measurement
tools gave a numerical readout of the kilopascals in differ-
ent areas of the examined ROI [16]. The quantitative max-
imum stiffness (termed ‘‘E-max”) on three acquisitions was
recorded for each mass [17].
We follow Athanasiou et al. and considered a cutoff
elasticity value 146.6 kPa ± 40.05 for malignant lesions
and 45.3 kPa ± 41.1 for benign lesions [4].2.2.2. Magnetic resonance mammography (MRM)
MRM was performed on a 1.5 T whole-body MR imag-
ing (MR Achieva) Philips medical systems using a bilateral
phased array breast coil. The imaging protocol corre-
sponded to the standard, dynamic, subtraction technique.
The breast was examined on a sagittal, coronal and axial
Fast Spin Echo T2-weighted imaging with fat suppression
(TR/TE 100/4000-6000); the field of view was adjusted to
cover the breast (260–320 mm) with a slice thickness of
4 mm, an acquisition matrix of 256  192, and a number
of excitations 2. A dynamic T1-weighted three-
dimensional, fat-suppressed fast-spoiled gradient-echo
sequence (17/2.4, flip angle 35, band width 31.25, slice
thickness 2–3 mm with no intersection gap) was then per-
formed before and three times after a rapid bolus injection
of 0.1 mmol/kg gadolinium-DTPA (Magnevist; Schering,
Berlin, Germany) using automated injector at a rate of 3–
5 ml/s through a 18–20 gauge cannula inserted in an
anti-cubital vein followed by flushing with 20 ml of saline.
Image acquisition began 35 s after administration of the
contrast and saline bolus (initial image within 2 min of
injection to detect maximum slope of the curve) followed
by another two sequences (for delayed sequence) within
the next 3 min (to detect established curve shape).
[18,19] Subtraction images were obtained by subtracting
the pre-contrast images from the post-contrast images.Evaluation of magnetic resonance images and classification of
lesions
Each lesion was reviewed and classified by the reader
according to the kinetics of the time signal intensity curve
of the enhancing lesions. Time–signal intensity curves of
each enhancing lesion were classified into type I, II or III
to differentiate malignant lesions and benign lesions. If
the dynamic study showed an initial strong enhancement
and a post initial washout or plateau between 2 and
5 min after bolus injection the lesion was considered
malignant, while a moderate initial increase and a post ini-
tial increase enhancement or plateau between 2 and 5 min
were considered benign.
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Core biopsy was done for 17 patients two of them gave
undetermined pathological data due to their small size. We
depended on the histopathological reports in our interpre-
tation after the surgical treatment (even for lumpectomy of
the benign lesions) as surgical treatment was the stated
protocol for management by surgical team of our research
and also in our institute for all BI-RADs 4 masses. After
histopathological diagnosis, the lesions were classified as
benign or malignant.2.4. Statistical analysis
Qualitative data were represented as frequencies and
relative percentages. Chi-square test was used to calculate
the difference between qualitative variables. Quantitative
data were expressed as mean ± SD (Standard deviation).
To calculate the difference between quantitative variables
in two groups in normally distributed data we used inde-
pendent T-test.
Diagnosis from, dynamic curves, elasticity scoring, and
SWE was compared with the histopathological diagnoses.Fig. 1. Column chart shows clinical pre
Fig. 2. Pie chart shows final histo-pathologicaSensitivity, specificity, positive predictive value, negative
predictive value and accuracy were illustrated.3. Results
There were 63 focal breast lesions in 63 women meet-
ing our inclusion criteria. Their ages ranged from 28 to
56 y with mean age 34.7 ± 5.9.
The most clinical presentation was palpable masses
presented in 52.3% Fig. 1. Histopathological evaluation of
the 63 lesions revealed 26 cases had benign lesions
(Fig. 2) and the remaining 37 cases had malignant lesion
(Fig. 3). The pathological diagnosis included 12 fibroadeno-
mas, 4 complicated cysts (3 fibrocystic changes and one
fibroadenoma with no signs of atypia), 4 cases of phyl-
lodes, 3 intracystic papillomas and 2 cases of fat necrosis
and one case of granulomatous mastitis. The malignant
cases were as follows: 27 cases infiltrating duct carcinoma
(IDC) (22 low grade and 5 high grade), 4 cases of Infiltrat-
ing lobular carcinoma (ILC), 4 cases of medullary carci-
noma, 1 case of lymphoma and 1 case as metastasis.
Using colored SE 20 cases out of the 26 benign cases had
a color score from 1 to 3 and 6 cases had score of 4 or 5;sentation of the studied patients.
l diagnosis of 26 benign breast lesions.
Fig. 3. Pie chart shows final Histo-pathological diagnosis of 37 malignant breast lesions.
Fig. 4. Column chart shows validity of SWE and DC-MRI.
Table 1
The predictive value of malignancy using SE score in BI-RADS 4 breast masses.
SE score Benign (26) (%) Malignant (37) (%) P value
1–3 20 76.9 4 10.8 <0.05
4–5 6 23.1 33 89.2
Table 2
Histopathological diagnosis and corresponding E-max shear wave velocity of the evaluated lesions in 63 patients in our study.
Final pathologic diagnosis of benign
breast lesions (26 cases)
E-max SWV
by kPa
Mean ± SD Final pathologic diagnosis of malignant




Fibroadenoma (n = 12) 10–105 27.4 ± 32.34 IDC low grade (n = 22) 89–184 142.4 ± 28.8
Complex cyst (n = 4) 12–111 45 ± 44.8 IDC high grade (n = 5) 122–198 160.2 ± 28.2
Phyllodes (n = 4) 18–66 34.5 ± 22 ILC (n = 4) 85–171 122 ± 42.9
Granulomatous mastitis (n = 1) 105 105 Medullary carcinoma (n = 4) 132–165 148 ± 13.5
Intracystic papilloma (n = 3) 25–86 50.7 ± 31.6 Lymphoma (n = 1) 156 156
Fat necrosis (n = 2) 18–40 29 + 15.6 Metastasis (n = 1) 123 123
SWV: shear wave velocity kPa: Kilo-Pascal.
1776 G. A. Elmoneam et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1773–1782however, only three malignant cases had SE score 1–3 and
the remaining 33 had score 4 or 5 with a significant
p-value < 0.05 (Table 1).
All patients were subjected to SWE and DC-MRI. The
mean E max velocity and the type of MRI dynamic curve
(I, II or III) of each pathological lesion were identified(Tables 2 and 3. From the 26 cases of histopathology proved
benign lesion, SWE recorded velocities ranged from 9 to
111 kPa, with only 4 lesions above the considered cut-off
value range of the benign lesions (45.3 kPa ± 41.1): 2 cases
were fibroadenoma (Fig. 5 and 6), one case complex cyst
and a case of granulomatous mastitis (Fig. 7). However, In
Table 3
Histopathological diagnosis and corresponding MRI dynamic curve type of 63 patients in our study.










I II III I II III
Fibroadenoma 10 1 1 IDC low grade 0 4 18
Complex cyst 4 0 0 IDC high grade 0 1 4
Phyllodes 4 0 0 ILC 0 1 3
Intracystic papilloma 3 0 0 Medullary carcinoma 0 0 4
Granulomatous mastitis 1 0 0 Lymphoma 0 0 1
Fat necrosis 2 0 0 Metastasis 0 0 1
Fig. 5. 32 years old female patient with positive family history, (A) MLO (medio-lateral oblique) mammography of the LT breast shows central an irregular
fine speculated mass (arrow), (B) US shows isoechoic well-defined mass with posteromedial single focal angulation (BIRADS 4). (C) In SE it displays score 4
with high kPa value (105). (D) Axial subtraction MRI shows central lateral-ward enhanced mass. (E) The signal–intensity curve shows rapid intense
enhancement and plateau pattern in delayed phase (type II curve). Histopathology proved highly cellular fibroadenoma.
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recorded velocities ranged from 85 to 198 kPa (Figs. 8 and
9) with only 3 lesions below the considered cut-off value
range of themalignant lesions (146.6 kPa ± 40.05): one case
of low-grade IDC (Fig. 10) and 2 cases of ILC.
Regarding dynamic-MRI, Type I curve was detected in
24 (92.3%) of the benign cases (Figs. 6 and 7) and none of
the malignant cases. Type II curve was detected in a case
of fibroadenoma (Fig. 5) and in 6 malignant cases (Figs 8and 10). However type III dynamic curve (Fig. 9) was
detected in 31 malignant cases (83.8%) and only one case
of fibroadenoma.
There were two cases (fibroadenomas) incorrectly
interpreted as malignant by both SWE and DC-MRI curves
(Fig. 5).
Fig. 4 displays a comparison between SWE, and DC-MRI
in BI-RADS 4 breast lesions. The sensitivity, specificity, PPV,
NPP and accuracy of the SWE using a cutoff velocity value
Fig. 6. 45 years old female patient with a localized lump in the breast. (A) MLO mammography of the LT breast shows lower dense mass with indistinct
lower margin as well as multiple bilateral axillary lymph nodes. (B) US shows mainly hypoechoic mass lesion with micro lobulation (BIRADS 4a). (C) In SE it
displays score 4 with high kPa value (100). (D) Axial subtraction MRI shows mainly homogeneous enhanced mass lesion. (E) The signal–intensity curve
shows early enhancement with progressive late increase in enhancement (type I curve). Histopathology revealed fibroadenoma.
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45.3 kPa ± 41.1 for benign lesions were 89.5%, 88%, 91.9%,
84.6% and 88.9%, respectively. The sensitivity, specificity,
PPV, NPP and accuracy of DC-MRI curve were 100%,
92.3%, 94.9%, 100% and 96.8%, respectively.
4. Discussion
We conducted a study of 63 female patients, their ages
ranged from 28 to 56 y with mean age 34.7 ± 5.9 years.
Sixty-three suspicious breast masses (42 palpable and 21
non palpable) were detected and categorized as BI-RADS
4 using X-ray mammography and US. The most presenting
symptom was localized lump in the breast found in 52.3%
followed by incidental mass detection during screening
mammography (27%). According to our study, Histo-
pathological evaluation of the 63 BI-Rad 4 lesions revealed
26 lesions (41.3%) as benign and 37 lesions (58.7%) as
malignant.
We found that fibroadenoma was the most common
benign lesion found in 46.2% of all benign lesions while
the most common malignant lesion was ductal carcinoma
represented in 59.5% of all malignant lesions (22 cases low
grade and 5 cases high grade), in agreement with other
studies, which reported fibroadenoma as the most com-
mon benign breast lesion 37.8%, and IDC as the most com-
mon malignant lesion 55.6% [20,21].
SE is useful for characterizing breast lesions in general
and has the potential to allow differentiation between
malignant and benign lesions [12–23]. Raza et al. [24]found that 84% of the malignant lesions, had an elasticity
score (ES) of 4–5, and 76% of benign lesions had an ES of
1–2. Similar results by Elsaid and Mohamed [22] reported
that 72% of benign lesions showed ES 1–2, and 84% of
malignant lesions showed ES 4–5; however, none of the
malignant lesions showed ES 1. These were in agreement
with our study, as, 79.9% of the benign lesions had ES
1–3, and 89.2% of malignant lesions had ES 4–5.
SWE can be used to quantitatively measure the lesion
stiffness. The stiffness of the malignant lesions is generally
high, and that of benign lesions is less. According to
Athanasiou et al., [4] the most malignant lesions have an
elasticity value of 146.6 kPa ± 40.05, while benign lesions
had an elasticity value of 45.3 kPa ± 41.1.
In our study, Most of the benign lesions showed SW
velocities below 45.3 kPa ± 41.1 with only four lesions
(one complex cyst, one granulomatous mastitis, and 2
fibroadenomas) above this mean value (false positive). All
fibroadenomas had velocity ranging from 10 to 105 kPa,
complex cyst 12–111 kPa, intracystic papilloma 41–
86 kPa, phyllodes 18–66 kPa, granulomatous mastitis
105 kPa, and fat necrosis 18–40 kPa, indicating that most
of themwere soft and had almost the same compressibility
as the surrounding breast tissue suggesting benign nature.
Malignant lesions in our study showed SW velocities
above 146.6 kPa ± 40.05, with only 3 lesions (one case of
IDC and two cases of ILC) below this mean value (false neg-
ative). IDC showed SW velocity ranging from 89 to 198 kPa,
ILC from 85 to 171 Kpa, Medullary carcinoma 132–165 kPa,
lymphoma 156 Kpa, and metastasis 123 kPa.
Fig. 7. 36 years female patient with localized pain in the left breast. (A) MLO mammography shows, upper focal dense zone with no definite masses
(arrow). (B) US shows an ill-defined heterogenous complex focal area that shows some turbid cystic spaces. (C) In SE it displays score 4 with high kPa value
(105). (D) Axial subtraction MRI with contrast and (E) time intensity curve shows an upper outer heterogeneous patchy area of enhancement with mild
initial enhancement and progressive enhancement in delayed phase (type I) curve. Histopathology proved non specific granulomatous mastitis.
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kPa values; however, BI-RADS 4 lesions - according to the
US - had their SW elasticity values in the borderline range,
with elasticity values for the malignant lesions ranged
from 100 to 102 kPa, and for the benign lesion was
99 kPa and referred this because, in malignant lesions
lower values were often found in their centers [16]. In
our study we avoid this by taking E-max SW velocity for
each lesion.
Berg et al. found that benign lesions were much softer
than malignancies (Emax, 43 kPa vs 180 kPa). They con-
cluded that, despite overlap in Emax values, maximum tis-
sue stiffness measured by SWE of the sonographically
depicted breast masses is a highly effective predictor of
their histopathological severity [17].
We had 4 cases with complex cysts and diagnosed as
BIRAD 4 by US and mammography. SWEwas able to down-
grade three of them to BI-RAD 3 (proved to be fibrocystic
changes with no atypia), as they showed velocity below
45.3 kPa ± 41.1, and the remaining case (proved to be
fibroadenoma with no atypia) recorded E-max 105 kPa
(false positive). This was in agreement with Lee et al.,
who discriminated 30 malignant lesions (21.4%) among
140 complex cysts and solid lesions depending on their
(E-max) SW velocity. They reported that, E-max of malig-
nant lesions (184.3 kPa) was significantly higher than that
of the complex cystic lesions (45.5 kPa) (p < 0.001) [25].Among different quantitative SWE parameters, E-max
with a cutoff at 45.1 kPa showed the highest sensitivity,
specificity, and accuracy (p < 0.0001) [26].
Au et al. concluded that adding the SWE quantitative
parameters to BI-RADS category 4 masses improved the
diagnostic performance of US [27]. This is in agreement
with our results as we found that, the sensitivity, speci-
ficity, and accuracy of SWE were 89.5%, 88%, and 88.9%
respectively.
In a meta-analysis by PubMed, Embase, and the
Cochrane library search, eleven articles published up to
2014, including 2424 patients, and the summarized sensi-
tivity and specificity of the SWE performance based on
maximum elasticity were 93% and 81%, respectively, and
when based on the mean elasticity, the summarized sensi-
tivity was 94% and the specificity was 71%. The reviewers
concluded that SWE based on E-max had higher specificity
than that based on mean elasticity in differentiating
between benign and malignant breast lesions.
The assessment of the type of time–signal intensity
curve (i.e., kinetic curve) is the most widely used form of
DCE-MRI analysis by categorizing the washout pattern of
a gadolinium contrast agent. These patterns are classified
as a progressive and persistent enhancement (type I),
which is suggestive of a benign lesion: Plateau type, with
intermediate probability for malignancy (type II), and
washout type which is indicative of malignancy (type III)
Fig. 8. 55 years female patient presented with left breast lump. (A) Cranio-caudal mammography reveals mainly central segmental dense breast
parenchyma with no definite lesions. (B) US shows fairly defined hypoechoic mass with areas of breakdown, at 2 o’clock (BIRADS 4). (C) In SE it displays
score 3, with more upgrading of the lesion by SWE as it gives high kPa value (132). (D) Axial subtraction MRI with contrast and (E) time intensity curve
shows heterogeneously enhanced mass like lesion with initial rapid enhancement and plateau pattern in delayed phase (type II curve). Histopathology
revealed IDC high grade.
1780 G. A. Elmoneam et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1773–1782[28]. The washout patterns are typically assessed qualita-
tively, with intra- and interobserver wide variability
reported to vary from 0.27 [29,30] to 0.80 [31].
Regarding kinetic MRI, Morris concluded that homoge-
neous enhancement is suggestive of a benign process;
however, one must be careful in small lesions as the spatial
resolution may limit the evaluation. Also, he concluded
that heterogeneous enhancement was the most frequent
enhancement pattern among the malignant lesions (96%)
[32].
In agreement with many studies [33,34], regarding the
type of dynamic curve we found that type 3 (wash out)
was noted in 31 malignant lesions and only one benign
lesion. Type 2 (plateau) was noted in 6 malignant lesions
and 1 benign lesion while type 1 (progressive rising) was
noted in 24 benign lesions and none of the malignant
lesions. Two cases proved by histopathology as fibroade-
noma were suspicious as malignant by DC-MRI curve (type
II and III) giving false positive results.
Gulnaz et al. reported that the sensitivity, specificity,
negative and positive predictive values of kinetic MRI for
detection of breast lesions were, 94%, 85%, 82% and 90%
respectively. The overall accuracy of MRI breast was 90%
[35].
In agreement with our results, the sensitivity, speci-
ficity, PPV, NPV and accuracy of MRI for breast lesions werefound to be 100%, 92.3%, 94,9%, 100%, and 96,8%
respectively.
These results disagree with Hetta W, who proved that
the sensitivity and specificity of DCE-MRI examination
were 80% and 73.33% respectively [34] and also disagree
with Kul et al. [28] who reported lower specificity
(75.7%) and whoever, similar high sensitivity (97.9%). This
may be due to the difference in nature of sample collection
regarding inclusion criteria.
Kuhl et al. [36] suggested that the kinetic information
might not evaluate in cases with definite malignant mor-
phological criteria. But, when the morphology suggested
a benign lesion or indeterminate criteria, they recommend
performing a time–signal intensity curve analysis, whereas
the authors recommend performing a biopsy in cases of
benign or indeterminate morphological criteria and a pla-
teau type II curve.
Our results have revealed that kinetic MRI using time-
signal intensity curve in addition to the quantitative
parameters of SE using SWE would be useful to differenti-
ate between benign and malignant masses for BI-RADS 4
breast masses so they can be valuable in preventing unnec-
essary biopsies, and also MRI dynamic curve was more
sensitive and more specific than SWE .
The limitation of our study was avoiding the large and
extremely superficial ulcerating masses which could not
Fig. 9. 48 years female patient came with localized RT breast lump. (A) MLOmammography shows an irregular deep central fine speculated mass harboring
wide area of microcalcification. (B) US shows mainly hypoechoic mass with speculation and posterior shadowing this lesion is perpendicular to skin with
surrounding architectural distortion (BIRADS 4c). (C) In SE it displays score 5 with high kPa value (145). (D) Axial subtraction MRI shows intense enhanced
mass and (E) time intensity curve shows rapid intense enhancement with rapid washout in delayed phase (type III curve). Histopathology proved ILC.
Fig. 10. 48 years female patient came for screening mammography. (A) Cranio-caudal mammography shows an irregularly outlined mass in the right inner
quadrant. (B) US shows hypoechoic solid mass lesion with an ill-defined margin (BIRADS 4). (C) In SE it displays score 2 with low kPa value (85). (D) Axial
subtraction MRI shows enhanced speculated mass and (E) time intensity curve shows initial rapid enhancement and plateau pattern in delayed phase (type
II curve). Histopathology revealed IDC low grade.
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1782 G. A. Elmoneam et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1773–1782be evaluated by SE as the unevenness of the skin surface
affected the reliability of the ultrasound elastography scan-
ning. Another limitation was the overlap in SWE values
that made it difficult to document a SWV specific range
and cutoff value for each pathological entity.Conflict of interest
The authors declare that there are no conflict of
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